Published in Cancer Clin Oncol on January 01, 2013
Combined P16 and human papillomavirus testing predicts head and neck cancer survival. Int J Cancer (2014) 0.98
Role of human papillomavirus in oropharyngeal squamous cell carcinoma: A review. World J Clin Cases (2014) 0.83
Epigenetic modulation of signal transduction pathways in HPV-associated HNSCC. Otolaryngol Head Neck Surg (2013) 0.81
Meta-analysis of survival in patients with HNSCC discriminates risk depending on combined HPV and p16 status. Eur Arch Otorhinolaryngol (2015) 0.79
Phase II study of cetuximab in combination with cisplatin and radiation in unresectable, locally advanced head and neck squamous cell carcinoma: Eastern cooperative oncology group trial E3303. Clin Cancer Res (2014) 0.78
FKBP51 Immunohistochemical Expression: A New Prognostic Biomarker for OSCC? Int J Mol Sci (2017) 0.75
A novel prediction model for human papillomavirus-associated oropharyngeal squamous cell carcinoma using p16 and subcellular β-catenin expression. J Oral Pathol Med (2015) 0.75
Detection of HPV in oral rinse samples from OPSCC and non-OPSCC patients. BMC Oral Health (2015) 0.75
Human Papilloma Virus Associated Squamous Cell Carcinoma of the Head and Neck. J Sex Transm Dis (2015) 0.75
The biological significance of methylome differences in human papilloma virus associated head and neck cancer. Oncol Lett (2016) 0.75
Human papillomavirus and survival of patients with oropharyngeal cancer. N Engl J Med (2010) 22.74
The mutational landscape of head and neck squamous cell carcinoma. Science (2011) 16.88
Improved survival of patients with human papillomavirus-positive head and neck squamous cell carcinoma in a prospective clinical trial. J Natl Cancer Inst (2008) 12.77
p15INK4B is a potential effector of TGF-beta-induced cell cycle arrest. Nature (1994) 10.95
Human papillomavirus types in head and neck squamous cell carcinomas worldwide: a systematic review. Cancer Epidemiol Biomarkers Prev (2005) 9.47
Alcohol drinking in never users of tobacco, cigarette smoking in never drinkers, and the risk of head and neck cancer: pooled analysis in the International Head and Neck Cancer Epidemiology Consortium. J Natl Cancer Inst (2007) 4.55
A novel algorithm for reliable detection of human papillomavirus in paraffin embedded head and neck cancer specimen. Int J Cancer (2007) 4.29
Mechanisms of human papillomavirus-induced oncogenesis. J Virol (2004) 3.95
Racial survival disparity in head and neck cancer results from low prevalence of human papillomavirus infection in black oropharyngeal cancer patients. Cancer Prev Res (Phila) (2009) 3.70
Effect of HPV-associated p16INK4A expression on response to radiotherapy and survival in squamous cell carcinoma of the head and neck. J Clin Oncol (2009) 3.70
Genetic patterns in head and neck cancers that contain or lack transcriptionally active human papillomavirus. J Natl Cancer Inst (2004) 3.67
Comparative prognostic value of HPV16 E6 mRNA compared with in situ hybridization for human oropharyngeal squamous carcinoma. J Clin Oncol (2009) 2.74
Active transcriptional repression by the Rb-E2F complex mediates G1 arrest triggered by p16INK4a, TGFbeta, and contact inhibition. Cell (1999) 2.48
A causal role for human papillomavirus in head and neck cancer. Lancet (2004) 2.21
The National Cancer Data Base report on cancer of the head and neck. Arch Otolaryngol Head Neck Surg (1998) 1.96
New markers for cervical dysplasia to visualise the genomic chaos created by aberrant oncogenic papillomavirus infections. Eur J Cancer (2002) 1.60
Real-time quantitative PCR demonstrates low prevalence of human papillomavirus type 16 in premalignant and malignant lesions of the oral cavity. Clin Cancer Res (2002) 1.53
Human papillomavirus in cervical and head-and-neck cancer. Nat Clin Pract Oncol (2008) 1.52
Prognostic significance of p16 protein levels in oropharyngeal squamous cell cancer. Clin Cancer Res (2004) 1.44
Racial/ethnic patterns of care for cancers of the oral cavity, pharynx, larynx, sinuses, and salivary glands. Cancer Metastasis Rev (2003) 1.34
Fine-mapping loss of gene architecture at the CDKN2B (p15INK4b), CDKN2A (p14ARF, p16INK4a), and MTAP genes in head and neck squamous cell carcinoma. Arch Otolaryngol Head Neck Surg (2006) 1.17
Cyclin D1 amplification and p16(MTS1/CDK4I) deletion correlate with poor prognosis in head and neck tumors. Laryngoscope (2002) 1.11
Human papillomavirus-active head and neck cancer and ethnic health disparities. Laryngoscope (2010) 1.10
Human papillomavirus-related squamous cell carcinoma of the oropharynx: a comparative study in whites and African Americans. Arch Otolaryngol Head Neck Surg (2011) 1.07
Human papillomavirus in metastatic lymph nodes from unknown primary head and neck squamous cell carcinoma. Otolaryngol Head Neck Surg (2011) 1.06
Race impacts outcome in stage III/IV squamous cell carcinomas of the head and neck after concurrent chemoradiation therapy. Cancer (2009) 1.05
Human papillomavirus, p16 and p53 expression associated with survival of head and neck cancer. Infect Agent Cancer (2010) 0.93
p16INK4A adenovirus-mediated gene therapy for human head and neck squamous cell cancer. Clin Cancer Res (1998) 0.90
Human papillomavirus outcomes in an access-to-care laryngeal cancer cohort. Otolaryngol Head Neck Surg (2012) 0.90
Molecular classification of breast carcinoma in situ. Curr Genomics (2006) 0.87
Clinical outcomes and adherence to medications measured by claims data in patients with diabetes. Diabetes Care (2004) 3.31
Patient-physician colorectal cancer screening discussions and screening use. Am J Prev Med (2006) 1.87
Improving asthma care through recertification: a cluster randomized trial. Arch Intern Med (2007) 1.54
Thiazolidinedione use and the longitudinal risk of fractures in patients with type 2 diabetes mellitus. J Clin Endocrinol Metab (2010) 1.36
Reducing the health risks of diabetes: how self-determination theory may help improve medication adherence and quality of life. Diabetes Educ (2009) 1.36
Inconsistencies in patient perceptions and observer ratings of shared decision making: the case of colorectal cancer screening. Patient Educ Couns (2010) 1.35
Colorectal carcinoma screening procedure use among primary care patients. Cancer (2005) 1.29
Methylation of multiple genes as diagnostic and therapeutic markers in primary head and neck squamous cell carcinoma. Arch Otolaryngol Head Neck Surg (2007) 1.28
Factors contributing to the racial differences in prostate cancer mortality. BJU Int (2005) 1.26
Multicenter cluster-randomized trial of a multifactorial intervention to improve antihypertensive medication adherence and blood pressure control among patients at high cardiovascular risk (the COM99 study). Circulation (2010) 1.22
Disparate in vitro and in vivo antileukemic effects of resveratrol, a natural polyphenolic compound found in grapes. J Nutr (2002) 1.19
Relationship between thiazolidinedione use and cardiovascular outcomes and all-cause mortality among patients with diabetes: a time-updated propensity analysis. Pharmacoepidemiol Drug Saf (2009) 1.18
Fine-mapping loss of gene architecture at the CDKN2B (p15INK4b), CDKN2A (p14ARF, p16INK4a), and MTAP genes in head and neck squamous cell carcinoma. Arch Otolaryngol Head Neck Surg (2006) 1.17
Epigenetic events of disease progression in head and neck squamous cell carcinoma. Arch Otolaryngol Head Neck Surg (2006) 1.16
Curcumin sensitizes prostate cancer cells to tumor necrosis factor-related apoptosis-inducing ligand/Apo2L by inhibiting nuclear factor-kappaB through suppression of IkappaBalpha phosphorylation. Mol Cancer Ther (2004) 1.16
Peak aerobic capacity predicts prognosis in patients with coronary heart disease. Am Heart J (2008) 1.15
Prioritization of evidence-based preventive health services during periodic health examinations. Am J Prev Med (2012) 1.14
Adherence analysis using visual analog scale versus claims-based estimation. Ann Pharmacother (2007) 1.12
Down-regulation of HLA-A and HLA-Bw6, but not HLA-Bw4, allospecificities in leukemic cells: an escape mechanism from CTL and NK attack? Blood (2003) 1.10
Long-term survival probability in men with clinically localized prostate cancer treated either conservatively or with definitive treatment (radiotherapy or radical prostatectomy). Urology (2006) 1.05
Immunomodulatory activity of curcumin: suppression of lymphocyte proliferation, development of cell-mediated cytotoxicity, and cytokine production in vitro. Biochem Pharmacol (2004) 1.04
The distribution of long range admixture linkage disequilibrium in an African-American population. Hum Hered (2002) 1.03
The economic impact of false-positive cancer screens. Cancer Epidemiol Biomarkers Prev (2004) 1.01
Aromatherapy as treatment for postoperative nausea: a randomized trial. Anesth Analg (2012) 0.97
E-cadherin status in breast cancer correlates with histologic type but does not correlate with established prognostic parameters. Am J Clin Pathol (2006) 0.97
Patient-physician colorectal cancer screening discussions: delivery of the 5A's in practice. Am J Prev Med (2011) 0.97
Effect of socioeconomic factors on long-term mortality in men with clinically localized prostate cancer. Urology (2009) 0.95
Patient-rated importance and receipt of information for colorectal cancer screening. Cancer Epidemiol Biomarkers Prev (2011) 0.95
Protective effect of diabetes against metastasis in patients with non-small cell lung cancer. Arch Intern Med (2007) 0.94
Colorectal cancer screening use among insured primary care patients. Am J Manag Care (2011) 0.93
Patient and tumor factors at diagnosis in a multi-ethnic primary head and neck squamous cell carcinoma cohort. J Surg Oncol (2009) 0.93
Real-time polymerase chain reaction for the rapid detection of group B streptococcal colonization in neonates. Pediatrics (2006) 0.93
Are there race/ethnicity differences in outpatient congestive heart failure management, hospital use, and mortality among an insured population? Med Care (2004) 0.91
Improved survival with HPV among African Americans with oropharyngeal cancer. Clin Cancer Res (2013) 0.90
Human papillomavirus outcomes in an access-to-care laryngeal cancer cohort. Otolaryngol Head Neck Surg (2012) 0.90
Micrometastatic tumor detection in patients with head and neck cancer: a preliminary report. Arch Otolaryngol Head Neck Surg (2002) 0.89
Molecular differentiation of early and late stage laryngeal squamous cell carcinoma: an exploratory analysis. Diagn Mol Pathol (2007) 0.89
An epigenetically derived monoclonal origin for recurrent respiratory papillomatosis. Arch Otolaryngol Head Neck Surg (2007) 0.89
Acute pancreatitis in patients on chronic peritoneal dialysis: an increased risk? Am J Gastroenterol (2005) 0.89
Benign breast disease heterogeneity: association with histopathology, age, and ethnicity. Breast Cancer Res Treat (2007) 0.89
The major histocompatibility complex gene region and sarcoidosis susceptibility in African Americans. Am J Respir Crit Care Med (2003) 0.88
DNA hypermethylation markers of poor outcome in laryngeal cancer. Clin Epigenetics (2010) 0.87
Molecular classification of breast carcinoma in situ. Curr Genomics (2006) 0.87
A comparison of smokers' and nonsmokers' fruit and vegetable intake and relevant psychosocial factors. Behav Med (2009) 0.87
Identification of individual genes altered in squamous cell carcinoma of the vulva. Genes Chromosomes Cancer (2005) 0.86
Immunomodulatory activity of resveratrol: discrepant in vitro and in vivo immunological effects. Biochem Pharmacol (2003) 0.86
DNA methylation in thyroid tumorigenesis. Cancers (Basel) (2011) 0.85
Chemosensitization of hormone-refractory prostate cancer cells by curcumin to TRAIL-induced apoptosis. J Exp Ther Oncol (2005) 0.85
Epigenetic events underlie the pathogenesis of sinonasal papillomas. Mod Pathol (2007) 0.85
Delineating an epigenetic continuum in head and neck cancer. Cancer Lett (2012) 0.84
Delineating an epigenetic continuum for initiation, transformation and progression to breast cancer. Cancers (Basel) (2011) 0.84
Race as a social construct in head and neck cancer outcomes. Otolaryngol Head Neck Surg (2011) 0.84
Recurrence of non-alcoholic steatohepatitis and cryptogenic cirrhosis following orthotopic liver transplantation in the context of the metabolic syndrome. Clin Transplant (2012) 0.84
DNA hypermethylation profiles in squamous cell carcinoma of the vulva. Int J Gynecol Pathol (2009) 0.83
Consistent DNA hypermethylation patterns in laryngeal papillomas. Int J Head Neck Surg (2010) 0.83
Mutations in the von Hippel-Lindau (VHL) gene refine differential diagnostic criteria in renal cell carcinoma. J Surg Oncol (2002) 0.83
Effect of ezetimibe on major atherosclerotic disease events and all-cause mortality. Am J Cardiol (2012) 0.83
Racial disparities in lipid control in patients with diabetes. Am J Manag Care (2012) 0.82
Iron overload in allogeneic hematopoietic stem cell transplant recipients. Arch Pathol Lab Med (2012) 0.82
Epigenetic modulation of signal transduction pathways in HPV-associated HNSCC. Otolaryngol Head Neck Surg (2013) 0.81
Vaccination with leukemia-loaded dendritic cells eradicates residual disease and prevent relapse. J Exp Ther Oncol (2006) 0.81
SPARC affects glioma cell growth differently when grown on brain ECM proteins in vitro under standard versus reduced-serum stress conditions. Neuro Oncol (2003) 0.81
Risk factors for emergency department use among children with asthma using primary care in a managed care environment. Ambul Pediatr (2002) 0.80
Molecular characterization of late stomal recurrence following total laryngectomy. Oncol Rep (2011) 0.79
Novel approaches to global mining of aberrantly methylated promoter sites in squamous head and neck cancer. Otolaryngol Head Neck Surg (2010) 0.78
Malignant and nonmalignant gene signatures in squamous head and neck cancer. J Oncol (2012) 0.78
Noninvasive molecular detection of head and neck squamous cell carcinoma: an exploratory analysis. Diagn Mol Pathol (2009) 0.78
Renal insufficiency after liver transplantation in the MELD era compared to the pre-MELD era. Clin Transplant (2009) 0.78
Identifying the risk factors for late-stage head and neck cancer. Expert Rev Anticancer Ther (2011) 0.77
Disparate molecular, histopathology, and clinical factors in head and neck squamous cell carcinoma racial groups. Otolaryngol Head Neck Surg (2012) 0.77
Promoter methylation in head and neck tumorigenesis. Methods Mol Biol (2012) 0.77
Nurse practitioners' and physicians' care activities and clinical outcomes with an inpatient geriatric population. J Am Acad Nurse Pract (2004) 0.77
Characterization of 10 vulvar carcinoma cell lines by karyotyping, comparative genomic hybridization and flow cytometry. Gynecol Oncol (2004) 0.76
Human papilloma virus (HPV) modulation of the HNSCC epigenome. Methods Mol Biol (2015) 0.76
Cell signaling events differentiate ER-negative subtypes from ER-positive breast cancer. Med Oncol (2015) 0.76
Human papilloma virus prevalence in a multiethnic screening population. Otolaryngol Head Neck Surg (2013) 0.75
Distinct Gene Profiles for Tumor and Non-Tumor Tissue in the Head and Neck: An Analytical Approach. J Cancer Sci Ther (2011) 0.75